Otsuka Launches New Company to Commercialize Rejoyn, the First Digital Therapeutic for Depression
Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The ...
Tuesday, January 7, 2025
Tag: Commercialize
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.